Cita APA

Falco, A., Leiva, M., Blanco, A., Cefarelli, G., Rodríguez, A., Melo, J., . . . Wasiberg, F. (2022). First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study. Web

Citación estilo Chicago

Falco, Agustín, et al. First-line Cisplatin, Docetaxel, and Cetuximab for Patients With Recurrent or Metastatic Head and Neck Cancer: A Multicenter Cohort Study. 2022.

Cita MLA

Falco, Agustín, et al. First-line Cisplatin, Docetaxel, and Cetuximab for Patients With Recurrent or Metastatic Head and Neck Cancer: A Multicenter Cohort Study. 2022.